Evoke Pharma Inc expected to post a loss of 38 cents a share - Earnings Preview

Evoke Pharma

06/11/2024 14:06

* Evoke Pharma Inc  EVOK.OQ   EVOK.O  is expected to show a
rise
in quarterly revenue when it reports  results on November 7
(estimated) for the period ending September 30 2024
    * The Solana Beach California-based  company is expected to
report
a 114.9% increase in revenue to $3.358 million from $1.56
million a year ago, according to the estimate from one analyst,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Evoke Pharma Inc is for
a loss
of 38 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Evoke
Pharma Inc
is $18.00​, above​ its last closing price of $5.79. ​​​

This summary was machine generated November 6 at 14:06 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)